Tudor Investment Corp’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
GS
SCM
WP
Tudor Investment Corp's RCUS Position: Q2 2026 in Review
Tudor Investment Corp sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 216,311 shares — an estimated $4.67M sold.
Tudor Investment Corp first reported a position in RCUS in Q1 2018 and held it in 13 quarters. The position peaked at $4.97M in Q4 2025. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.
- Tudor Investment Corp reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
- Tudor Investment Corp sold 216,311 Arcus Biosciences shares in Q2 2026, an estimated $4.67M.
- Tudor Investment Corp first reported a position in Arcus Biosciences in Q1 2018 and held it in 13 quarters.
- Tudor Investment Corp's Arcus Biosciences position peaked at $4.97M in Q4 2025.
- 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.